Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
infection
Biotech
Seres to lay off 30% of employees, pause lead program
Just months after laying off a quarter of its workforce, Seres is sending more employees to the exits.
James Waldron
Feb 12, 2026 9:55am
Pulmocide pulls ph. 3 antifungal trial over mortality rate
Jan 7, 2026 10:57am
Seres shrinks head count by 25% to fund biotherapeutic's ph. 2
Sep 23, 2025 10:00am
Recce's synthetic gel treats skin infections in ph. 2
Feb 19, 2025 8:39am
X4 scores a phase 3 win for immune deficiency disorder drug
Nov 30, 2022 10:45am
Could a single pill outsmart a tumor's resistance mechanisms?
Mar 29, 2021 10:00am
